elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36584337-5C0C72B5-F41C-419E-B8F3-E3C766099BA7
Q36584337-5C0C72B5-F41C-419E-B8F3-E3C766099BA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36584337-5C0C72B5-F41C-419E-B8F3-E3C766099BA7
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.
P2860
Q36584337-5C0C72B5-F41C-419E-B8F3-E3C766099BA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36584337-5C0C72B5-F41C-419E-B8F3-E3C766099BA7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
747c0b031e4a7b33fbbb4f70928c2db3e87964ff
P2860
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.